Healthcare Industry Parkinson's Disease Therapeutics Market Trends | Page 4

Your Catalyst To a Lucrative Business
4.3. Asia Pacific
4.3.1. Asia Pacific Parkinson’s disease therapeutics market, by product, 2012 – 2019, (USD Million)
4.4. RoW
4.4.1. RoW Parkinson’s disease therapeutics market, by product, 2012 – 2019, (USD Million)
Chapter 5. Key Company Profiles
5.1. Novartis
5.1.1. Company overview
5.1.2. Product portfolio
5.1.3. Financial overview
5.1.4. Recent developments
5.2. Teva Pharmaceuticals
5.2.1. Company overview
5.2.2. Product portfolio
5.2.3. Financial overview
5.2.4. Recent developments
5.3. GlaxoSmithKline
5.3.1. Company overview
5.3.2. Product portfolio
5.3.3. Financial overview
5.3.4. Recent developments
5.4. Boehringer Ingelheim
5.4.1. Company overview
5.4.2. Product portfolio
5.4.3. Financial overview
5.4.4. Recent developments
5.5. Merck Serono
5.5.1. Company overview
5.5.2. Product portfolio
5.5.3. Financial overview
5.5.4. Recent developments
5.6. Orion Corporation
5.6.1. Company overview
5.6.2. Product portfolio
5.6.3. Financial overview
5.6.4. Recent developments
Follow Us: